XML 49 R29.htm IDEA: XBRL DOCUMENT v3.19.3
Merger Agreement (Details)
3 Months Ended 9 Months Ended
Jul. 24, 2019
USD ($)
director
shares
Jul. 23, 2019
USD ($)
Sep. 30, 2019
shares
Sep. 30, 2019
shares
Oct. 31, 2019
USD ($)
Oct. 29, 2019
USD ($)
Oct. 28, 2019
USD ($)
Merger Agreement              
Number of contingent value right per share 1            
Percentage of gross consideration 80.00%            
Contingent Value Rights Term 15 years            
Contingent value rights term incase of other than grant, sale or transfer 10 years            
Commitment to support develop gemcabene $ 1,000,000            
Cash payment days 30 days            
Restricted stock awards              
Merger Agreement              
Granted (in shares) | shares     607,000 607,000      
Dr. Gullans              
Merger Agreement              
Employment Agreement, Severance Cash Lump Sum Payments $ 75,000            
Dr. Gullans | Restricted stock awards              
Merger Agreement              
Granted (in shares) | shares 300,000            
Dr. Bisgaier              
Merger Agreement              
Employment Agreement, Severance Cash Lump Sum Payments $ 330,000            
Dr. Bisgaier | Restricted stock awards              
Merger Agreement              
Granted (in shares) | shares 100,000            
Mr. Reno              
Merger Agreement              
Employment Agreement, Severance Cash Lump Sum Payments $ 297,536            
Mr. Reno | Restricted stock awards              
Merger Agreement              
Granted (in shares) | shares 100,000            
Non-employee director | Restricted stock awards              
Merger Agreement              
Granted (in shares) | shares 45,000            
Employees | Restricted stock awards              
Merger Agreement              
Granted (in shares) | shares 62,000            
Merger Agreement with NeuroBo              
Merger Agreement              
Percentage of interest held by our exiting shareholders 96.26% 3.74%          
Merger agreement, minimum parent cash amount $ 3,400,000            
Termination fee $ 1,000,000            
Total number of directors | director 10            
Number of directors to be designated | director 9            
Prior retention of gross consideration $ 500,000            
Merger Agreement with NeuroBo | Minimum              
Merger Agreement              
Merger agreement, minimum parent cash amount 3,750,000            
Merger Agreement with NeuroBo | Maximum              
Merger Agreement              
Threshold Gross Proceeds to Adjust Ownership Percentage 50,000,000            
Reimbursement of expenses 500,000            
Merger Agreement with NeuroBo | Series B Preferred Stock              
Merger Agreement              
Minimum required amount from preferred stock financing $ 24,240,000            
License Agreement with Beijing SL              
Merger Agreement              
Upfront payment to be received   $ 2,500,000          
Period from effective date within which upfront gross payment to be paid   45 days          
Developmental and regulatory milestone payment eligible to be received   $ 6,000,000          
Global net sales milestone payment to be received   $ 20,000,000          
Subsequent Event | Merger Agreement with NeuroBo              
Merger Agreement              
Merger agreement, minimum parent cash amount           $ 3,750,000,000,000 $ 3,000,000,000,000
Subsequent Event | License Agreement with Beijing SL              
Merger Agreement              
Upfront payment to be received         $ 2,500,000